Difference between revisions of "Loxoprofen"
m (Bot: links syntax and spacing) |
m (1 revision) |
(No difference)
|
Latest revision as of 21:16, 21 September 2010
250px | |
250px | |
Systematic (IUPAC) name | |
---|---|
(RS)-2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid | |
Clinical data | |
Routes of administration | Oral, transdermal |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 97% |
Metabolism | Hepatic glucuronidation |
Biological half-life | 75 minutes |
Excretion | Renal |
Identifiers | |
CAS Number | 68767-14-6 |
ATC code | M01AE (WHO) |
PubChem | CID 3965 |
Chemical data | |
Formula | C15H18O3 |
Molar mass |
246.302 g/mol 304.314 g/mol (sodium salt)[[Script error: No such module "String".]] |
Loxoprofen (INN) is a non-steroidal anti-inflammatory drug in the propionic acid derivatives group, which also includes ibuprofen and naproxen among others. It is marketed in Brazil, Mexico and Japan by Sankyo as its sodium salt, loxoprofen sodium, under the trade name Loxonin, Argentina as Oxeno and in India as Loxomac . It is available in these countries for oral administration, and a transdermal preparation was approved for sale in Japan on January 2006.[1]
Pharmacokinetics
Loxoprofen is a prodrug. It is quickly converted to its active trans-alcohol metabolite following oral administration, and reaches its peak plasma concentration within 30 to 50 minutes.
Mechanism of action
As most NSAIDs, loxoprofen is a non-selective cyclooxygenase inhibitor, and works by reducing the synthesis of prostaglandins from arachidonic acid.
Interactions
Loxoprofen should not be administered concomitantly with second-generation quinolone antibiotics such as ciprofloxacin and norfloxacin, as it increases their inhibition of GABA and this may cause seizures.[2] It may also increase the plasma concentration of warfarin, methotrexate, sulfonylurea derivatives and lithium salts, so care should be taken when loxoprofen is administered to patients taking any of these drugs.[2]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
40x40px | Wikimedia Commons has media related to [[commons:Category:{{#property:P373}}|Loxoprofen]]. |
- ↑ Daiichi Sankyo Co. (January 24, 2006). "Percutaneous Absorption-Type Analgesic and Anti-inflammatory Drug Loxonin Poultice 100mg Receives Approval for Manufacture" (Press release). Doctor's Guide Global Edition. http://www.pslgroup.com/dg/2570a2.htm. Retrieved 2007-04-19.
- ↑ 2.0 2.1 (Portuguese) "LOXONIN - Bula do Medicamento [Label Information]". Centralx. 2007. Retrieved 2007-04-19.
- Pages with script errors
- Pages with broken file links
- Infobox drug articles with non-default infobox title
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Commons category with page title different than on Wikidata
- 2Fix
- Non-steroidal anti-inflammatory drugs
- Prodrugs
- Ketones